Cargando…
Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells
INTRODUCTION: Hepatocellular carcinoma (HCC) is the most common form of hepatic malignancy in the world. We aimed to determine the effect of tanshinone IIA (Tan-IIA) in combination with sorafenib or its derivative SC-1 on cytotoxicity, apoptosis, and metastasis in human HCC cells. MATERIALS AND METH...
Autores principales: | Chiu, Chien-Ming, Huang, Sung-Ying, Chang, Shu-Fang, Liao, Kuan-Fu, Chiu, Sheng-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881525/ https://www.ncbi.nlm.nih.gov/pubmed/29636623 http://dx.doi.org/10.2147/OTT.S161534 |
Ejemplares similares
-
Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling
por: Huang, Sung-Ying, et al.
Publicado: (2017) -
Potential Therapeutic Roles of Tanshinone IIA in Human Bladder Cancer Cells
por: Chiu, Sheng-Chun, et al.
Publicado: (2014) -
The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG
por: Lv, Chao, et al.
Publicado: (2018) -
Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study
por: Chan, Szu-Erh, et al.
Publicado: (2011) -
Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug
por: Li, Hu, et al.
Publicado: (2023)